Health Awareness
Women are underdiagnosed, undertreated and under-represented in heart disease
A landmark consensus in Heart1 (BCS/BMJ) confirmed that, despite heart disease being the leading cause of death in women, they remain underdiagnosed, undertreated and underrepresented in all aspects of care.
The article showed that women are less likely to receive life-saving treatment in an emergency, less likely to be given medication to prevent a heart attack or stroke and less likely to have their heart issues taken seriously. Women are also treated based on evidence gained from male-only research studies, whereas their symptoms and treatment needs can be different.
Heart disease prevention in women
Together, the group of authors from across the British Cardiovascular Society and our affiliated societies, led by Professor Vijay Kunadian of Newcastle University, proposes a series of over 50 measures across the different disease areas to improve women’s access to diagnosis, treatment and preventive care. These far-reaching measures will address all levels of the issue, from broad-based awareness campaigns to prevent heart disease and help women recognise their own risks to changing the way healthcare staff approach signs and symptoms more prevalent in women.
identifying areas of practice where heart disease may present differently in women; reducing waiting times for tests and treatment; researching the right doses of drugs for women; and extra training for healthcare staff on heart disease in pregnant and menopausal women.
professionals will need training to become more attuned to women’s specific needs.
Importantly, the statement calls for a ‘holistic woman-centred approach to heart care that listens to and incorporates women’s experiences and insights’ and information that is tailored to the needs of women. It highlights heart conditions that predominantly or exclusively affect women. Healthcare professionals will need training to become more attuned to women’s specific needs, including women’s cardiac symptoms.
Women’s hearts matter
The final recommendation is that ‘every woman should feel that her heart matters.’ It will take time and effort to redress the balance in women’s cardiovascular health, but we are committed to making that a reality.
The future of heart health with AI-powered devices and treatment approaches
Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic; it’s a real-world tool, transforming patient care and outcomes.
One of the key areas where AI is making a significant impact is in the early detection of cardiovascular diseases (CVD). Traditional methods often fail to diagnose CVD before symptoms appear, leading to delayed treatment and poorer outcomes. AI, however, can analyse vast amounts of data from electrocardiograms (ECGs) and other diagnostic tools to identify early signs of heart disease that might be missed by human eyes, which improves diagnostic accuracy and patient outcomes.1
Personalising cardiology treatment
AI also plays a crucial role in personalising treatment plans. By analysing patient data, AI can help doctors tailor treatments to individual needs, ensuring that each patient receives the most effective therapy. This personalised approach is particularly beneficial in managing complex conditions like heart failure, where treatment needs to be adjusted frequently based on the patient’s response.
AI-powered digital devices
Women-centred research and training
Specific recommendations include ensuring women are included in research studies and undertaking some women-only studies;
UK & IE
Project Manager: Nikki Martincic nikki.martincic@mediaplanet.com
healthcare professionals confident about realising the full potential of these AI-powered technologies and tools. Healthcare professionals already face an exponential rise in medical information which is doubling at least every 73 days.3 Furthermore, the integration of AI into healthcare systems requires robust data privacy measures and regulatory oversight to ensure patient safety and data security.4
Fully and safely realising AI capabilities
By analysing patient data, AI can help doctors tailor treatments to individual needs.
AI is poised to transform cardiology by enhancing early disease detection, personalising treatment and improving overall care quality. As technology continues to evolve, the potential for AI to improve outcomes for patients with cardiovascular disorders is immense; however, ongoing education is needed in its widespread adoption to ensure it is being utilised to its full capabilities. The future of cardiology is bright, with AI leading the way towards more efficient, accurate and personalised care.
References:
The use of wearable and portable devices is another exciting development in AI cardiology. These devices, such as smartwatches and portable ECG monitors, enable continuous monitoring of heart health, providing real-time data to both patients and healthcare providers. This continuous monitoring can lead to early intervention and better management of chronic conditions, ultimately reducing hospitalisations and improving quality of life.2
Effective AI integration in healthcare
Despite these advancements, there are still significant challenges to overcome when it comes to getting
1. Attia, Z.I., et al. (2019). ‘An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction’, The Lancet, 394(10201), pp. 861–867. doi: 10.1016/ S0140-6736(19)31721-07.
2. Khunte, A., et al. (2023). ‘Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices’, NPJ Digital Medicine, 6(1), p. 124. doi: 10.1038/s41746-023-00869-w.
3. Koenig, H.G. (2012) ‘Religion, spirituality, and health: The research and clinical implications’, International Scholarly Research Notices, 2012, pp. 1–33. doi: 10.5402/2012/278730.
4. Chustecki M. Interact J Med Res. 2024;13:e53616; Davenport T, et al. Future Healthc J. 2019;6:94-98; Khera R, et al. J Am Coll Cardiol. 2024;84:97-114; Khera R, et al. JAMA. 2023;330:22552257.
(0) 203 642 0737
WRITTEN BY Professor André Ng President, British Cardiovascular Society
WRITTEN
Reimagining medicine, together
Introduction of routine scan has prevented thousands of heart attacks
We estimate around 6,000 heart attacks in the UK have been avoided in the last decade,1 thanks to the introduction of new a routine heart scan.
Coronary computed tomography angiogram (CCTA) scans help doctors to identify coronary heart disease, narrowing and blockages in the arteries that supply the heart with blood. If left untreated, coronary heart disease can lead to a heart attack.
Coronary computed tomography angiogram trial
Since 2016, UK guidelines have recommended CCTA scans as one of the first tests for someone experiencing new chest pain. The results of our SCOT-HEART trial2 fed into the evidence for the update. Now, our research, part funded by the British Heart Foundation and published in The Lancet, shows that the benefits of CCTA scans extend as far as a decade beyond a patient’s scan.
CCTA scans reduce heart attacks
Our 10-year follow up of the SCOT-HEART trial3 found that the number of non-fatal heart attacks in the group who had a CCTA scan was 28% lower compared to those who had standard tests. Applied across the UK population and the current rate of CCTA use, we estimate that this equates to 6,000 heart attacks avoided over the last 10 years.1
This is likely due to more people in the CCTA group being prescribed preventative medicines. At 10 years, 56% of the group were taking medicines — including aspirin and statins — to reduce their risk of a heart attack compared to 49% in the standard tests group.
Improving long-term outcomes for more people
Early results showed that people who had CCTA scans were more likely to undergo additional procedures in the first year after their scan. By five years, the number of procedures had evened out between the groups, but the CCTA group were less likely to have had a heart attack and more likely to be taking preventative drugs.
However, access to CCTA scans remains variable across the country. We want to see more opportunities for testing across the UK to address this, such as the community diagnostic hubs being rolled out by the NHS in England, so that more people can benefit from this game-changing innovation.
References
1. Piercy L. 2025. British Heart Foundation. Routine scans prevent thousands of heart attacks.
2. The Lancet, Volume 385, Issue 9985, 2383 – 2391. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial.
3. Williams Michelle C et al. The Lancet, Volume 405, Issue 10475, 329 – 337. Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOTHEART randomised controlled trial in Scotland.
WRITTEN BY
Professor Michelle Williams
Why weight stigma creates barriers for obesity patients in healthcare
People with obesity often feel shame and avoid sharing their experiences of stigma. We encourage the community to raise awareness about the harm caused by this stigma.
Weight stigma is common in the workplace. International Coalition for People Living with Obesity (ICPO) members report they see the microaggressions on an interviewer’s face when they enter the room or are told they didn’t get the promotion despite conducting an excellent interview.
Forms of obesity stigma in society
In society, people may avoid sitting beside someone living with obesity on public transport. On TV, we see people living with obesity ridiculed. Assumptions are often made that people who carry excess weight are not driven to be active or take part in sports, which is often untrue.
negatively, making them less likely to continue seeking care. Often, patients have a delayed diagnosis as the healthcare provider does not see past the weight. Assumptions are often high that a person has not lost weight before or doesn’t take their health seriously, and the words used are harmful.
Stigma in healthcare is one of the forms of discrimination that directly affects patients negatively.
More complex is the stigma that comes from family. It is now reported in research to be the highest-reported form of stigma above that in healthcare. It is incredibly difficult to address, as it is almost entirely unintentional and unrecognised within the family.
How does a seven-year-old respond when they are brought to a slimming group by their mum so that they fit into a communion dress? Or, how would they respond to a parent who says they cannot sleep at night because they worry you are going to die of a heart attack?
Healthcare stigma impacts patients Stigma in healthcare is one of the forms of discrimination that directly affects patients
After being subjected to multiple forms of stigma often on a daily basis, it is no surprise to understand that self-internalised stigma is prevalent for people living with obesity. This stigma is deeply rooted in the beliefs many have. It results in low self-esteem, depression and anxiety, maladaptive eating behaviours and, most worryingly, avoidance of healthcare.
People with obesity need support
People living with obesity want a better quality of life and better health. They are more invested in their welfare than you may believe. They just need to be listened to, supported and respected like everyone else.
How a weight loss procedure turned one man’s life around
A minimally invasive procedure to reduce stomach volume is a way to help people with obesity achieve significant weight loss. One person who has had the treatment tells their story.
Yves Renuixen had always been fit and healthy. As someone who enjoyed walking regularly and going to the gym four or five times a week, gaining weight was the furthest thing from his mind. That all changed in 2019 when he was given a CT scan following an infection and received a shock cancer diagnosis.
Struggle with weight and health issues
“I was told I had a tumour on my spleen and needed surgery,” says Renuixen. “When the Covid-19 lockdowns started, I was classed as ‘clinically extremely vulnerable’ because I no longer had a spleen and couldn’t leave the house.” Being unable to exercise took a mental and physical toll. Feeling isolated and depressed, he put on over 50kg (7.8 stone) and at his heaviest weighed more than 152kg (23.9 stone). In 2023, his doctor referred him to dietitians and a psychologist. Despite this, Renuixen’s weight struggles continued.
Life-changing minimally invasive procedure
In May 2024, the team at St Mary’s Hospital explained that he was suitable for a minimally invasive procedure called endoscopic sleeve gastroplasty (ESG) which had received positive guidance from the National Institute for Health and Care Excellence (NICE).1 Designed to benefit patients living with obesity, ESG is performed under general anaesthetic, takes around 90 minutes and involves a thin, flexible tube with a small camera being passed through the mouth and into the stomach. 2 Most ESG procedures can be performed as a day procedure.
Boston Scientific manufactures minimally invasive medical device solutions, including the OverStitch™ Endoscopic Suturing System, 2 which is used during ESG procedures. The OverStitch device is attached to the end of the tube to stitch and fold together parts of the stomach wall to reduce its volume by 70%–80%. 3 This reduces food intake by creating a sensation of fullness. When combined with diet and exercise, the ESG procedure can help those affected by obesity to lose weight.
Renuixen was the first patient to have ESG at St Mary’s, and the results have been life-changing. “I met the team around 8am, and the procedure was done by 10.30am,” he says. “It all felt very quick, and I didn’t feel sore, so it was kind of amazing. I was discharged just before 3pm and went back to my normal activities the next day. 4”
A ‘reset’ that offers a life-improving confidence boost
After the procedure, ESG patients reintroduce food slowly into their diet, progressing from liquid to solid food. While Renuixen needed to re-learn the capacity of his stomach, eating is still a pleasure. “I now eat less but still enjoy what’s on my plate,” he says, referring to his ESG procedure as a ‘reset button.’ “At a certain stage of a weight problem, it’s mental as much as physical, so exercise and dieting may only help so much. You need to reset.”
Regaining control
Now cancer-free and exercising regularly, he’s almost back to his normal weight. “I’m going to the gym five times a week, and I’ve joined a running club,” says Renuixen. “Seeing the transformation of your body is a boost to keep going. You stop hiding behind oversized clothes. You become more social. That’s what this procedure has done for me. It’s given me control over my life and my confidence back.”
References 1-4 available upon request from gastroenterologyEuro@bsci.com
INTERVIEW WITH Yves Renuixen Patient
WRITTEN BY Tony Greenway
Yvesbefore surgery Images providedbyBoston
Yves after surge ry
Social care fix needed to prevent more difficult winters for the NHS
Although the weather has improved, the NHS continues to feel the strain of a challenging winter, with high flu and norovirus levels adding pressure to an already overstretched healthcare system.1
The NHS went into this winter facing record demand across GP surgeries and A&Es. This is fuelled by an ageing and increasingly unwell population, which often has more complex or multiple health conditions for clinicians to manage.
Corridor care has become normalised
Despite their best efforts, NHS staff have had to resort to caring for patients in corridors or overflow wards — practices that were unthinkable a decade ago.2 This has sadly become normalised following the combination of rising demand, years of underinvestment and a spike in winter viruses. Corridor care not only compromises patient privacy, dignity and safety but can also leave NHS staff subject to the moral injury of being unable to provide the care they would like to.
One of the key challenges is the lack of social and community care, which leads to delays in discharging medically fit patients out of hospital. This causes bottlenecks throughout the urgent and emergency care system, which can leave ambulances queuing outside hospitals and patients waiting hours to be transferred to wards from A&Es.
Preventing further tough winters We must make sure that the NHS does not face another winter like the last few, which have been some of the worst in its history.3 Tackling corridor care will take a concerted effort across the health and social care systems so that patient flow in and out of hospitals can be improved. Work already underway includes setting up same-day emergency care services, urgent community response programmes and wraparound care
innovations.
We look forward to working with the Government and NHS England on implementing the urgent and emergency care improvement plan. The NHS will not be able to improve urgent and emergency care performance until the challenges across social care are also addressed. The upcoming Casey Commission into social care is a welcome development, with wholesale reform the only means to achieve the improved adult social care system that the NHS — and the public — needs.
References: 1. https://www.england.nhs.uk/statistics/statistical-workareas/uec-sitrep/urgent-and-emergency-care-dailysituation-reports-2024-25/
2. https://www.rcn.org.uk/news-and-events/news/ uk-corridor-care-devastating-testimony-shows-patientsare-coming-to-harm-160125
3. https://www.england.nhs.uk/statistics/statistical-workareas/ae-waiting-times-and-activity/
Ending the silence on painful and heavy periods
This Endometriosis Month, let’s end the stigma around menstrual health. With many women not getting help for period pain and heavy bleeding, it’s time for change. It’s not ‘just a period.’
WRITTEN BY Janet Lindsay Chief Executive Officer, Wellbeing of Women
Contrary to popular belief, heavy bleeding and pain during periods do not only affect an ‘unlucky few.’
Wellbeing of Women found 62% of women aged 16-40 suffer from severe period pain, with nearly 30% experiencing heavy bleeding most or every period.
Period stigma persists
Women deserve better, yet menstrual health discussions remain shrouded in stigma. On average, women wait 22 months before seeking help for difficult period symptoms. Heavy bleeding and pain are often dismissed by friends, family and healthcare professionals, forcing generations of women to endure debilitating symptoms. Period mishaps are common — affecting 86% of those who menstruate — yet 77% would feel ashamed if it happened publicly, and 45% even in private.
Impact beyond ‘just a period’
adenomyosis and fibroids, delays in treatment can result in A&E admissions, blood transfusions, emergency, complex and riskier surgeries and can even impact fertility — all with additional, significant costs to the NHS.
In December 2024, the Women and Equalities Select Committee highlighted that lack of education, societal stigma and medical neglect have led to gynaecological conditions being overlooked. This is despite up to one in three women living with heavy menstrual bleeding and 1 in 10 having endometriosis or adenomyosis.
Women face a loss of jobs, careers and financial independence, as they struggle to cope with symptoms that are often dismissed.
For young girls, the impact is profound. They miss out on education and social plans, as pain and heavy bleeding often keep them confined to their beds. Women face a loss of jobs, careers and financial independence, as they struggle to cope with symptoms that are often dismissed. In progressive and chronic conditions such as endometriosis,
Period symptom checker
To address this, Wellbeing of Women has developed a Period Symptom Checker, helping women identify symptoms, seek appropriate care and advocate for their health. Ending the stigma requires better education, public awareness, increased research funding and workplace support. Menstrual health is a societal issue; when women are well, everyone benefits.
The Just a Period Campaign aims to ensure no one is held back by period symptoms. By understanding what’s normal, women can seek timely care and take control of their health.
WRITTEN BY Rory Deighton Acute Director, The NHS Confederation
Fuel poverty partnership helps people stay safe,
warm and healthy
at home
With fuel poverty having a devastating impact on people’s physical and mental health, a Birmingham initiative is supporting those who are unable to keep warm and well at home.
If you can’t afford to heat your home, it won’t just affect your ability to keep warm. It can severely impact your physical and mental wellbeing, too. With fuel poverty affecting an estimated 6 million people nationwide, Cadent –the country’s largest gas distribution network – recently released new statistics from its Energy Diaries insights series. It revealed that almost one in three Brits feel their physical health has been negatively impacted by decisions to save money on heating their homes.
How fuel poverty impacts health
“There’s a strong link between fuel poverty, cold homes and health,” says Phil Burrows, Head of Vulnerability and Social Purpose. “A cold home is a damp home, which exacerbates conditions such as asthma and bronchitis. Evidence suggests that it can also lead to heart problems and respiratory illnesses. Plus, if you’re living in a cold and damp environment, it can have a detrimental effect on mental health.”
Surprisingly, fuel poverty could also have an impact on hospital beds in the UK. If a patient is hospitalised due to an illness caused by living in a cold house, for example, doctors will be reluctant to discharge them back home where their condition could worsen. It’s the same for patients without a working fridge, as they won’t be able to store their medicine at the correct temperature.
Offering vulnerable Birmingham residents support
Last September, Cadent and the Cadent Foundation joined forces with Birmingham Community Healthcare NHS Foundation Trust
Charity to create a brand-new service called Well & Warm. The £2.4 million initiative aims to provide in-home energy efficiency interventions over the next two years for Birmingham residents living in fuel and general poverty. Birmingham was chosen as a pilot because the West Midlands has the highest fuel poverty rate in the country.
At the heart of the initiative is the Direct Access to Wellbeing Services Team (DAWS), which operates in the community and hospitals across Birmingham. Health practitioners — including doctors, nurses, midwives and health visitors — can now refer those in fuel poverty to DAWS for help and advice.
Holistic approach to fuel poverty
“DAWS provides energy support to those living in vulnerable situations, helping them to get the best out of their home heating solutions,” explains Burrows. “The team signposts to general medical guidance while working alongside Cadent experts to ensure gas appliances in eligible patients’ homes are checked and serviced to confirm they are safe and working efficiently. Additionally, the initiative ensures patients receive financial guidance, as well as health and carbon monoxide advice, ultimately enabling residents to live safe, warm and independent lives at home.”
Burrows adds: “This is a flagship initiative and joined-up, holistic approach to fuel poverty, which we’re committed to rolling out in other areas. We’ve been told by those who have benefitted from it that being able to afford to put the heating on — or having their boiler fixed so that they can be discharged from hospital — is nothing short of life-changing.”
How Mandeep got support from DAWS — and her heating back on
A mum of six from Birmingham couldn’t afford to have her boiler fixed, which was a catastrophe for her and her family — until the Direct Access to Wellbeing Services (DAWS) team got involved and solved the issue.
When her boiler broke down, Mandeep — a mother of six from Birmingham — couldn’t afford to have it fixed. In desperation, she had to boil kettles for hot water and use electric heaters and electric blankets to keep her family warm. This went on for several months which was a real struggle with six children.
“It’s been incredibly difficult for us to not be able to bathe or keep warm,” says Mandeep. “Even to wash, we would have to fill up buckets of water.” When Mandeep investigated to see if she could get a free boiler, she was told she wasn’t eligible.
Helping people stay well and warm at home Thankfully, Mandeep’s health visitor recommended that she get in touch with the new DAWS team, which got her heating and hot water back on within three days. Stories like this are heartbreaking in the 21st century but not uncommon — something Birmingham Community Healthcare NHS Foundation Trust has recognised.
Suzanne Cleary, Chief Officer for Strategy and Partnerships and Deputy CEO, says: “Every day, we see firsthand the hard choices people must make with regards to heating their homes and the detrimental impact this can have on their physical and mental health. The DAWS initiative means that we are able to help local people to stay well and warm at home.”
For Mandeep, DAWS was a lifeline. “I wouldn’t want anyone to go through what my family has been through,” she says. “If it wasn’t for the support I received from this team, I wouldn’t be here today.”
INTERVIEW WITH Suzanne Cleary Chief Officer for Strategy and Partnerships & Deputy CEO, Birmingham Community Healthcare NHS Foundation Trust
WRITTEN BY Tony Greenway
Transforming women’s health in Wales: a decade of change
The first Women’s Health Plan for Wales illustrates a 10-year vision to improve healthcare services for women and tackle the gender health gap.
Launched December 2024 by the NHS Wales Executive, the Women’s Health Plan for Wales is spearheaded by the National Strategic Clinical Network for Women’s Health. This clinically led, multiprofessional network is an enabler of the wider NHS Wales National Clinical Framework and works between NHS health boards and Welsh Government while engaging with patient groups and the third sector.
Equitable health services for all women
The network will work with NHS Wales Executive’s other national strategic clinical networks to ensure a coordinated, collaborative and evidence-based approach to address how NHS Wales will provide equitable health services for women across all conditions.
Sarah Murphy, Minister for Mental Health and Wellbeing, explains: “This plan is the culmination of an immense effort, and I extend my gratitude to the National Strategic Clinical Network for Women’s Health for their dedication. But this is just the beginning; the real work starts now.”
Key women’s health initiatives
The plan sets out nearly 60 actions to be achieved in short (<2 years), medium (3–5 years), and long-term (6–10 years) phases. Key actions include the formation of Women’s Health Hubs across all NHS Wales Health Boards to offer dedicated services tailored to women’s specific needs; the creation of a National Women’s Health Dashboard to provide real-time data tracking health metrics; and delivery of educational initiatives to increase understanding of women’s health conditions.
Research and innovation will drive success Life Sciences Hub Wales recently supported researchers from Cardiff, Bangor and Swansea Universities, which have subsequently secured £3 million in catalytic funding from Health and Care Research Wales to launch a Women’s Health Research Centre within Cardiff University. Life Sciences Hub Wales helps researchers, innovators and industry partners secure funding and accelerate impact.
Shaping the future
By prioritising women’s health, Wales is setting a new standard in patient-centred, research-driven and technologically advanced healthcare. The plan lays the foundation for a more equitable and effective healthcare system, ensuring better outcomes for women across the country.
The gynaecology care crisis in
the UK — and how to overcome it
The number of women in the UK currently waiting for hospital gynaecology services would fill Wembley Stadium eight times over.
WRITTEN
Ranee Thakar President, Royal College of Obstetricians and Gynaecologists
Many women are waiting for months and even years with serious conditions that have a devastating impact on almost every aspect of their lives, including their physical and mental health and their ability to work and socialise. Gynaecological conditions like endometriosis and fibroids are progressive and can become more complex to treat over time, meaning the longer women are waiting, the worse their condition becomes.
investment in obstetrics and gynaecology services per woman in England, there is an estimated return on investment of £11. This provides evidence that tackling the gynaecology care crisis will benefit not only thousands of individual women but also the wider economy. If we get it right for women, everyone can benefit.
Improving women’s health services
Waiting lists for gynaecology have grown faster than any other specialty since the pandemic.
Investment in women’s health boosts economy Waiting lists for gynaecology have grown faster than any other specialty since the pandemic, and the reasons behind the lists are complex and multi-faceted. It is particularly concerning to see that often, the most deprived areas in the UK face the longest waiting lists. This risks further compounding health inequalities between the most deprived and least deprived groups in our society.
The case for economic investment in Women’s Healthcare is fundamentally clear; a recent NHS Confederation report found that for every additional £1 of public
While it is encouraging to see the Government commit to improving waiting times through action like the new elective recovery plan, we hope to see muchneeded further commitments to improving women’s health set out in an updated Women’s Health Strategy and within the NHS 10-Year Plan this year.
The RCOG also firmly believes that implementing the Women’s Health Hub model is a crucial part of elective recovery and improving women’s healthcare. The hubs will better integrate all women’s health services and ensure women can see specialists at the right time, in the right place — with their symptoms recognised and managed quickly.
Time to make fertility care more trauma-informed
New research from a leading national charity highlights how a lack of trauma-informed care can exacerbate the already distressing experience of infertility and its treatment.
Fertility Network’s research shows the massive mental health impact of fertility problems, with most fertility patients experiencing depression and anxiety, and 40% reporting suicidal feelings.
Infertility-related trauma is more common than previously recognised
What the charity’s latest research highlights is that infertility-related trauma is far more common than previously recognised. A survey of 590 fertility patients found that 41% of respondents met criteria for post-traumatic stress disorder (PTSD) and complex PTSD, according to the International Trauma Questionnaire. The research was co-produced with the British Infertility Counselling Association and researchers at Cardiff University, Cardiff Metropolitan University and Queen’s University Belfast.
Fertility care exacerbates or causes trauma
Events most associated with trauma
The reproductive events most associated with traumatic experiences included ectopic pregnancy, one or more unsuccessful IVF cycles, miscarriage and baby loss, stillbirth and unsuccessful treatment as a whole. In many cases, it was the repetitive or cumulative effect of distressing events that seemed to exacerbate the trauma.
It was the repetitive or cumulative effect of distressing events that seemed to exacerbate the trauma.
While some patients reported positive experiences, worryingly, the majority of patients (61.2%) said aspects of the care they received made trauma worse. Only a minority of respondents (16.1%) reported healthcare professionals (HCPs) discussed infertility-related trauma with them, and only 1 in 4 patients (27.6%) said HCPs put in place support to help them cope with infertility-related trauma.
Evidence-based fertility options to help guide your
parenthood decisions
State-of-the-art, personalised fertility care — delivered by a multidisciplinary team of experts — offers hope and support for all types of family building.
FPatients also described how poor care, such as dismissive or conflicting advice, poor or insensitive communication, mistakes and delays and no forewarning or explanations about negative outcomes, compounded the traumatic events.
Trauma-informed care can make a difference
However, the research revealed how traumainformed care can make a difference.
Acknowledgement of the experiences as traumatic, signposting to specialist trauma therapy, better information to manage expectations of success and discussion of the emotional aspects of treatment, all helped.
Patients who were able to access appropriate specialist trauma therapy at an early stage, such as EMDR (eye movement desensitisation and reprocessing) therapy and trauma-informed CBT counselling, also reported less impact. It’s time to make trauma-informed fertility care standard for all.
ertility difficulties affect as many as one in six heterosexual couples1 and three in five over the age of 40.2 However, advancements in reproductive medicine now offer more options than ever. The Assisted Conception Unit (ACU) at London’s Guy’s Hospital (part of Guy’s and St Thomas’ NHS Foundation Trust) is one of the UK’s largest NHS fertility clinics. It offers state-of-the-art fertility options to support individuals and couples — whether they are starting their journey, exploring parenthood options or preserving fertility for the future.
Evidence-based, supportive fertility care
The ACU’s expert multidisciplinary team of doctors, nurses, embryologists and counsellors is dedicated to using precise, evidence-based approaches to maximise success. “Our fertility specialists only provide treatments that truly enhance outcomes,” says Dr Julia
Kopeika, consultant gynaecologist and subspecialist in reproductive medicine and surgery. “We do not support the use of ‘add-ons’ when there is clear evidence that they do not improve treatment outcomes. We believe that fertility treatments should be guided by scientific benefits rather than unproven methods.
“We work with each patient to personalise their treatment plan, carefully managing expectations and recommending interventions based on individual needs. Counselling and emotional support are also available free of charge, ensuring holistic and patientcentred care.”
Comprehensive fertility treatments
The ACU offers a full spectrum of fertility treatments including ovulation induction, in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI) and surgical sperm retrieval
(MicroTESE). It also has the UK’s largest pre-implantation genetic testing (PGT) service — treatment for couples with known genetic conditions at risk of having a child who might inherit a genetic condition — and performs more than half of PGT cycles in the country. Its fertility preservation service is among the largest globally, providing advanced treatment options such as egg, sperm and embryo freezing, ovarian tissue cryopreservation and OncoTESE. These services support individuals looking to preserve their reproductive potential, including those undergoing cancer treatments or choosing to delay parenthood.
Access and inclusivity
For NHS treatments, patients must meet certain eligibility criteria, but self-funded packages are available. Dr Kopeika adds: “We welcome everyone exploring their journey into parenthood including those with complex medical conditions, cancer patients, individuals undergoing gender-affirming therapies and those with cultural needs.”
“As fertility science advances, so do the opportunities for those hoping to start a family,” says Dr Kopeika. “We’re proud to lead the way with our commitment to research and excellence and ensuring that patients have access to trusted fertility care and the most innovative treatments available.”
References: 1. World Health Organization. 2023. 1 in 6 people globally affected by infertility: WHO. 2. BMJ. 2003 Aug 23;327(7412):434–436. doi: 10.1136/ bmj.327.7412.434. 3. Heffner LJ. Advanced maternal age--how old is too old? N Engl J Med. 2004 Nov 4;351(19):1927-9. PMID
Paid for by Guy’s and St Thomas’ Specialist Care
WRITTEN BY Dr Julia Kopeika Consultant Gynaecologist and Subspecialist in Reproductive Medicine & Surgery, Assisted Conception Unit (ACU), Guy’s Hospital (part of Guy’s and St Thomas’ NHS Foundation Trust)
WRITTEN BY
Sharon Martin
Interim Chief Executive, Fertility Network UK
Endometriosis misdiagnosis and changing the course of care
Endometriosis care has been neglected, harming patients and the economy. This Endometriosis Action Month, governments must take bold action to improve care for the 1 in 10 affected in the UK.
If we are to debunk the myths that are riddled within our society about endometriosis, such as ‘It’s just a bad period’ or ‘It’s just part of being a woman,’ we must all accept our responsibility in standing up for the injustice that those with the disease face — in accessing a diagnosis and treatment, at work and in being believed for the pain those with symptoms are experiencing.
Supporting people with endometriosis
We simply cannot afford to ignore the fact that it still takes, on average, nearly nine years to get a diagnosis of endometriosis in the UK — a statistic that has not changed in over a decade. We must also ensure that everyone with the disease receives prompt
access to treatment and the support they need to thrive at every point in their life. This takes governments, employers, healthcare practitioners at every level and the public to join our fight for change.
Endometriosis UK hears all too often that symptoms go ignored, dismissed and misdiagnosed, which can have a huge impact on all aspects of someone’s life, including their physical and mental health, friendships and relationships, education, career and fertility. The lifelong cost of failing to support those with endometriosis in both physical and mental health cannot be overstated.
Return of investing in endometriosis care Awareness is increasing, and
A breakthrough in endometriosis diagnosis through salivary RNA and AI
For millions of women, endometriosis remains a debilitating and underdiagnosed condition, often taking seven to 10 years to identify due to the limitations of current diagnostic methods.
WRITTEN BY
Norbert Nabet
Ziwig is transforming the field with pioneering technology, combining next-generation sequencing (NGS), salivary RNA analysis and artificial intelligence (AI) to provide a fast, reliable and noninvasive diagnostic solution: Ziwig Endotest®️. The test uses salivary microRNA (miRNA) sequencing to identify patterns linked to endometriosis. Advanced AI algorithms analyse large datasets, quickly identifying miRNA patterns for accurate early-stage detection. This technology improves diagnosis, reduces uncertainty and speeds up access to appropriate care. With 97.4% sensitivity and 93.5% specificity, the test offers a precise alternative to invasive tests and symptom-based assessments, leading to better patient outcomes.
From innovation to global access
In a major step toward making early diagnosis more accessible, French health authorities have approved fast-track reimbursement for 25,000 patients across 80 specialised medical centres under the Innovation Funding framework. This marks a significant shift in addressing the diagnostic gap, ensuring timely care for thousands of women.
Ziwig Endotest®️ is already available across Europe and the Middle East, reaching 20 countries. Further expansion
conversations are starting to shift, but this must be matched with clear action from the Government. There is mounting economic evidence that the Government simply cannot afford to ignore. A recent report by NHS Confederation shows that for every £1 per woman in England put into obstetrics and gynaecology, there is an estimated return of £11 per woman. Investing in endometriosis care will not only reduce suffering for those with endometriosis but will also save the NHS time and resources, as well as benefit the wider economy. Now is the time to act, so please join us this March and beyond in campaigning for change.
is underway in regions like Asia and South America, highlighting Ziwig’s commitment to making innovative diagnostic solutions available to women worldwide.
Beyond endometriosis: pioneering the future of diagnostics
This salivary RNA technology shows promise beyond endometriosis. The company is exploring new applications in oncology, neurology and gynaecology, with ongoing studies targeting ovarian cancer, amyotrophic lateral sclerosis (ALS) and other complex diseases. This breakthrough technology is paving the way for precision medicine, where non-invasive molecular diagnostics are standard for early detection.
Recognised for its innovation in women’s health, Ziwig was awarded the Galien International Prize 2024. The company are reshaping the way women’s health is prioritised, studied and treated. With Ziwig Endotest®️, a new era of faster, more precise and accessible diagnostics begins — empowering women and influencing the future of healthcare.
WRITTEN BY Faye Farthing Head of Communications, Endometriosis UK
Paid for by Ziwig
Dr
Head of Public Health, Ziwig
BImportance of regular breast checking and attending breast screening
Know the importance of early detection of breast cancer, regular breast checking and attending breast screening appointments when invited.
reast Cancer Now wants every woman to know the importance of early detection, regular breast checking and to feel educated and empowered to know the signs and symptoms of the disease.
Get to know your normal with TLC
Early detection of breast cancer is key; the sooner it’s diagnosed, the more likely treatment will be successful. So, it’s important that all women know the signs and symptoms and get to know their ‘normal’ through regular breast checking. Breast cancer can cause a number of signs and symptoms and while most breast changes — including breast lumps — are not cancer, it’s important to get any change checked by your GP.
five years. However, there is still work to do as thousands of women miss having their breast cancer detected through screening each year. Women in deprived areas and certain minority ethnic groups face a higher risk of late breast cancer diagnosis due to significant health inequalities. Worryingly, these women are also less likely to attend regular breast screening, which is one of the issues driving these disparities.1
Improving public awareness of breast screening
Breast checking only takes a few minutes.
Breast checking only takes a few minutes. There’s no right way to do it, as long as it’s done regularly. It could be while getting dressed, showering or putting on moisturiser. It’s as simple as ‘Touch, Look, Check (TLC).’ Touch your breasts. Look for changes. Check any new or unusual changes with a GP.
Importance of routine breast screening
Breast screening is a key tool for detecting breast cancer early. In England, the minimum target for women taking up their screening invite has just been met for the first time in
Why early lichen sclerosus diagnosis and treatment are
crucial
Lichen sclerosus is a chronic inflammatory skin condition causing patchy, discoloured and thin skin, mainly in genital and anal areas. It mostly affects postmenopausal women and prepubescent girls. However, it can impact anyone, including men.
Lichen sclerosus symptoms typically include itching, pain, skin changes, soreness and painful intercourse. If left untreated, it can lead to infections, vulval ulceration and an increased risk of cancer.
What causes lichen sclerosus?
The exact cause of lichen sclerosus remains unclear, though it is believed to involve genetic, hormonal, irritative, traumatic and infectious factors. Often classified as an autoimmune disorder, it is associated with antibodies targeting a specific protein. In women, the condition is most common after menopause.
What are the treatment options?
The first-line treatment for lichen sclerosus is typically the use of potent topical corticosteroids.
As part of our #NoTimeToWaste campaign, Breast Cancer Now, along with its supporters, has been calling for a national campaign in England to promote breast screening. It is also calling for the Government to provide a service that’s convenient and equitable for everyone eligible.
We were thrilled that NHS England announced a dedicated nationwide awareness campaign last month, targeted at those who need it most. Not only will this be a step forward in improving public understanding of breast screening and its importance, but it will crucially encourage more people to take up their invitation. We want to remind anyone affected by breast cancer that we can provide information and support — in every way we can, all year round.
Reference: 1.
However, because this condition is often chronic, many patients require lifelong steroid maintenance therapy along with regular follow-ups. In more severe cases, surgery may be necessary to widen the vagina or remove the foreskin. Recently, studies have shown that laser treatment is emerging as a promising alternative to corticosteroids, offering patients another potential solution.
Laser vs. corticosteroid therapy
Laser therapy is emerging as a viable option for patients who do not respond to corticosteroids or wish to reduce long-term steroid use.1 With corticosteroids, applying the correct amount with precision is essential. This treatment generally needs to be applied daily or, in some cases, twice weekly. Even when a patient is in remission, maintenance therapy
is often required along with regular check-ups.
In contrast, laser therapy typically requires three sessions spaced two to four weeks apart, with followup sessions every six months. Randomised controlled trials have demonstrated that laser therapies using Fotona’s Nd:YAG and Er:YAG lasers help reduce inflammation and can be just as effective as topical corticosteroids, with no significant adverse effects.2 Patients reported minimal discomfort during the treatment, and results showed significant improvements that can last up to six months. To enhance effectiveness further, laser therapy can be combined with corticosteroid treatment.
When should you seek help?
Symptoms of lichen sclerosus are often dismissed as a normal part of ageing, which may prevent women from seeking medical advice. However, women’s health is always worth a conversation. If you notice symptoms like itching, pain and skin changes, talk to your doctor. Early intervention can prevent complications and help manage the condition more effectively. By exploring available treatment options, we can improve quality of life and ensure that those suffering from lichen sclerosus receive the care they need.
References 1. doi: 10.1016/j.jogc.2019.01.023 2.doi.org/10.1111/1471-0528.17737
Breast Cancer Now (2023). Our blueprint to transform breast screening by 2028.
WRITTEN BY
Manveet Basra
Associate Director of Public Health, Inclusion and Awareness, Breast Cancer Now
WRITTEN BY
Urska Kanduc
Copywriter, Fotona
Does your workplace understand hormone health?
Rising awareness of hormone health demands recognition of the impact of symptoms on women in the workplace.
With rising awareness of hormone health comes the need to recognise the impact of symptoms on women in the workplace. Coupled with this is a new focus on achieving gender equity at work which must include being menstruation and menopause friendly.
The recently updated Employment Rights Bill now demands all organisations with over 250 employees have a Gender Action Plan to address the gender health gap. Central to this is enabling people to recognise their own symptoms and be empowered to ask their employer for help and reasonable adjustments to enable them to be their best at work.
Breaking the menstruation taboo
We must break the taboo attached to talking about periods and menstrual health conditions to facilitate open, helpful conversations. Replacing the stigma with knowledge and understanding in the workplace will promote gender equity and ensure female colleagues feel supported and valued at work.
Experience tells me that employers and line managers both want and welcome training on how to support their employees. Combining such training with wider awareness of menstrual health symptoms and support solutions across the entire workplace is key to changing people’s attitudes and creating a culture where gender-specific issues are understood, respected and managed.
Knowledge is power
The Employment Rights Bill asks for a Gender Action Plan, and we know this simply isn’t possible without being menstruation and menopause friendly. Yet, this approach shouldn’t just be for larger organisations — every employer needs to address this. After all, who would want to work for an organisation that doesn’t take the wellbeing of their colleagues seriously?
Knowledge is power, for both employer and employee. Often, we hear that people don’t want to talk about their symptoms as they fear what their boss will say. We also hear from employers who don’t know how to have that all-important conversation as they fear not knowing what to say. It’s time to break this vicious circle and accelerate action by educating people on menstrual health symptoms; training managers on what to look for and how to help; and raising awareness within workplaces so that talking about menstrual health is no longer taboo.
WRITTEN BY
Deborah Garlick CEO and Founder, Henpicked, Menopause in the Workplace